Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2016 |
8-K
| Quarterly results, Appointed a new director |
| 06/03/2016 |
8-K
| Appointed a new director|
Docs:
|
"Certificate of Designation of Rights, Preferences and Privileges of Series B Preferred Stock of Lion Biotechnologies, Inc.“, to be filed with the Secretary of State of Nevada prior to the closing of the private placement",
"Form of Securities Purchase Agreement, among Lion Biotechnologies, Inc. and the Investors thereunder",
"Form of Securities Purchase Agreement, among Lion Biotechnologies, Inc. and the Investors thereunder",
"Form of Registration Rights Agreement, by and among Lion Biotechnologies, Inc. and the Investors thereunder",
"Form of Registration Rights Agreement, by and among Lion Biotechnologies, Inc. and the Investors thereunder",
"Severance Agreement and General Release, between Lion Biotechnologies, Inc. and Dr. Elma Hawkins",
"Severance Agreement and General Release, between Lion Biotechnologies, Inc. and Dr. Elma Hawkins",
"Board Adviser Agreement, between Lion Biotechnologies, Inc. and Dr. Elma Hawkins",
"Board Adviser Agreement, between Lion Biotechnologies, Inc. and Dr. Elma Hawkins" |
|
|
|